Literature DB >> 11036684

Progress and prospects of ergot alkaloid research.

J Mukherjee1, M Menge.   

Abstract

Ergot alkaloids, produced by the plant parasitic fungi Claviceps purpurea are important pharmaceuticals. The chemistry, biosynthesis, bioconversions, physiological controls, and biochemistry have been extensively reviewed by earlier authors. We present here the research done on the organic synthesis of the ergot alkaloids during the past two decades. Our aim is to apply this knowledge to the synthesis of novel synthons and thus obtain new molecules by directed biosynthesis. The synthesis of clavine alkaloids, lysergic acid derivatives, the use of tryptophan as the starting material, the chemistry of 1,3,4,5-tetrahydrobenzo[cd]indoles, and the structure activity relationships for ergot alkaloids have been discussed. Recent advances in the molecular biology and enzymology of the fungus are also mentioned. Application of oxygen vectors and mathematical modeling in the large scale production of the alkaloids are also discussed. Finally, the review gives an overview of the use of modern analytical methods such as capillary electrophoresis and two-dimensional fluorescence spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036684     DOI: 10.1007/3-540-45564-7_1

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  2 in total

1.  Enantioselective synthesis of (+)-isolysergol via ring-closing metathesis.

Authors:  Jason A Deck; Stephen F Martin
Journal:  Org Lett       Date:  2010-06-04       Impact factor: 6.005

Review 2.  Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems.

Authors:  Iara Baldim; Wanderley P Oliveira; Varsha Kadian; Rekha Rao; Nitesh Yadav; Sheefali Mahant; Massimo Lucarini; Alessandra Durazzo; Raquel Da Ana; Raffaele Capasso; Selma B Souto; Antonello Santini; Eliana B Souto
Journal:  Biomolecules       Date:  2020-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.